Veradigm Inc. (MDRX)
| Market Cap | 729.19M |
| Revenue (ttm) | 588.02M |
| Net Income (ttm) | -86.46M |
| Shares Out | 169.58M |
| EPS (ttm) | -0.77 |
| PE Ratio | n/a |
| Forward PE | 13.07 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,234 |
| Average Volume | 233,539 |
| Open | 4.200 |
| Previous Close | 4.350 |
| Day's Range | 4.200 - 4.350 |
| 52-Week Range | 4.000 - 11.800 |
| Beta | 0.56 |
| RSI | 37.83 |
| Earnings Date | Mar 18, 2025 |
About Veradigm
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR softwa... [Read more]
Financial Performance
Financial StatementsNews
Syracuse Orthopedic Specialists Selects Veradigm to Achieve Exceptional Financial Health and Operational Efficiency
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Syracuse Orthopedic Specialists has selected elements from the...
Veradigm Inc. (MDRX) Investor Update Call Transcript
Veradigm Inc. (OTC:MDRX) Investor Update Call March 19, 2025 8:00 AM ET Company Participants Jenny Gelinas - VP, IR Tom Langan - Interim CEO Lee Westerfield - Interim CFO Conference Call Participants ...
Veradigm Inc (MDRX) Reports Fiscal 2023 Revenue Between $620M-$625M and Net Income of ...
Veradigm Inc (MDRX) Reports Fiscal 2023 Revenue Between $620M-$625M and Net Income of $62M-$65M; Projects 2024 Revenue Decline and Net Loss
Veradigm Announces Appointment of Two New Independent Directors and Transition of Board Leadership
CHICAGO--(BUSINESS WIRE)--Veradigm Inc. (OTCMKTS: MDRX) (“Veradigm” or the “Company”), a leading provider of healthcare data and technology solutions, announced today its Board of Directors (the “Boar...
Veradigm Provides Updates on Fiscal 2023 and 2024 and an Outlook for Fiscal 2025
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, provided updates on financial information for fiscal 2023 and 2024 and an outlook f...
Veradigm Files Fiscal 2022 Form 10-K and Restated Financial Statements
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that it filed its comprehensive Annual Report on Form 10-K for the ...
Veradigm to Release Financial Update March 18th and Host Investor Call March 19th
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that management plans to provide a financial update after the close...
Over 3,500 Healthcare Practices Receive Gaps-in-Care Alerts at the Point-of-Care via Veradigm Payer Insights Solution
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that over 3,500 healthcare practices across the United ...
Veradigm Becomes First EHR Media Platform to Achieve POCMA Certification
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, has become the first and only electronic health record (EHR) media prov...
Veradigm agrees to board refreshment in settlement with Kent Lake Capital
Veradigm will add four new directors to its board in an agreement with investor Kent Lake Capital, the healthcare technology company said on Thursday just weeks after concluding a strategic review.
Veradigm Announces Board Expansion and Changes
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX) (“Veradigm” or the “Company”), a leading provider of healthcare data and technology solutions, announced today it has entered into a Coo...
Veradigm Amends and Extends Stockholder Rights Plan
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced that its Board of Directors (the “Board”) has approved ...
Veradigm Introduces Cardiometabolic Clinical Registry Datasets to Enhance the Next Generation of Real-World Research
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today the launch of its disease-specific cardiometabolic Clin...
Veradigm Inc (MDRX) Stock Dips Amid Market Volatility
Veradigm Inc (MDRX) Stock Dips Amid Market Volatility
Black Book Ranks Veradigm EHR the #1 Ambulatory EHR for Family Practice and Primary Care Practices
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book Research, a leader in healthcare indust...
Veradigm ends strategic review after no firm bids
Veradigm (MDRX) ends strategic review after receiving no firm proposals. Potential bidders included McKesson, Oracle, and Thoma Bravo.
Veradigm Concludes Exploration of Strategic Alternatives and Announces Operational Review
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that the Veradigm Board of Directors (the “Board”) comp...
Veradigm Announces the Resignation of Board Director Beth Altman Due to Health Reasons
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced that on January 28, 2025, Beth Altman stepped down from...
Veradigm Inc (MDRX) Stock Drops 5% Amid Market Volatility
Veradigm Inc (MDRX) Stock Drops 5% Amid Market Volatility
Veradigm Adds Social Determinants of Health and Mortality Data to EHR Database to Allow Deeper Insights into the Patient Journey
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced the integration of two new datasets to expand the depth...
Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX)
NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Veradigm Inc. (OTCMKTS: MDRX) concerning the Company and its directors' and officers' possible violations ...
Veradigm Inc (MDRX) Stock Surges Amidst Financial Report Insights
Veradigm Inc (MDRX) Stock Surges Amidst Financial Report Insights
Veradigm Launches an Ambient Scribe Advancement to Ease the Healthcare Administrative Burden
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today the launch of Veradigm Ambient Scribe, an artificial intelligence (...
Veradigm Advancing Point of Care Engagement Through Payer-Provider Collaboration
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced an enhanced strategic collaboration with Insiteflow, an electronic ...
Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy +
The 'Undercovered' Dozen series highlights 12 lesser-covered stocks from the past week, aiming to spark ideas and discussions among retail investors. Veradigm Inc. is undervalued due to regulatory pre...